Patents by Inventor Catherine Sylvia Borg-Capra

Catherine Sylvia Borg-Capra has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of screening for triacyglycerol hydrolase inhibitors
    Patent number: 6861233
    Abstract: The invention relates to methods of identifying therapeutic agents which inhibit triacyglycerol hydrolase (TGH) activity, defined as TGH inhibitors, which are useful in the treatment of conditions resulting from elevated circulating levels of TG, VLDL/LDL-cholesterol and ApoB-100. Also claimed are therapeutic agents which are TGII inhibitors, identifiable by such methods and their use in combating diseases associated with elevated circulating levels of TG, VLDL/LDL-cholesterol and ApoB-100.
    Type: Grant
    Filed: August 24, 2000
    Date of Patent: March 1, 2005
    Assignees: Glaxo Group Limited, The Governors of the University of Alberta
    Inventors: Catherine Sylvia Borg-Capra, Richard Jiri Lehner, Dennis Edward Vance